Nasdaq · CIK 0000849146
LFVN Lifevantage Corp
Insider trading from SEC Form 4. Last filing 4 d ago. Close $6.00 on Oct 9, 2026, +51% from the 52-week low and -43% from the high.
In brief
Lifevantage Corp (LFVN) has 85 SEC Form 4 filings on file from 14 insiders, the latest filed on Oct 9, 2026. In the last 90 days insiders made 1 open-market buy worth $6,071 and 1 open-market sell worth $56k, net -$50k.
19 open-market trades have been scored at LFVN. The newest: Darwin Lewis (director) bought $6,071 of stock on Sep 15, 2026, filed Sep 17, 2026, scored 0 (weak), under a 10b5-1 plan. The largest of the 19 shown: Michael A Beindorff (director) sold $250k on Nov 7, 2025, scored 48 (moderate). 2 insiders sold within 14 days of each other around Feb 10, 2025.
5 Form 144 notices of planned sales are on file, the latest filed Jun 3, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Lifevantage Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Darwin Lewis director buy | $6,071 976 shares | +1% | - | |
| 22Weak | Kristen Cunningham Chief Sales Officer sell | $56k 9,001 shares | -7% | - | |
| 3Weak | Darwin Lewis director buy | $6,059 705 shares | +1% | +65% from low-53% from high | |
| 29Weak | Michael A Beindorff director sell | $85k 10,000 shares | -19% | +108% from low-41% from high | |
| 8Weak | Darwin Lewis director buy | $5,518 1,055 shares | +1% | +15% from low-69% from high | |
| 54Moderate | Judd Dayton director buy | $152k 33,197 shares | +70% | +3% from low-72% from high | |
| 38Weak | Darwin Lewis director buy | $21k 3,955 shares | +3% | +10% from low-75% from high | |
| 18Weak | Darwin Lewis director buy | $5,265 805 shares | +1% | +3% from low-74% from high | |
| 29Weak | Michael A Beindorff director sell | $81k 12,607 shares | -22% | +2% from low-75% from high | |
| 48Moderate | Michael A Beindorff director sell | $250k 36,000 shares | -99% | +10% from low-71% from high | |
| 13Weak | Darwin Lewis director buy | $4,882 450 shares | +0% | +9% from low-58% from high | |
| 27Weak | Michael A Beindorff director sell | $49k 4,325 shares | -16% | +27% from low-53% from high | |
| 13Weak | Carl Aure Chief Financial Officer sell | $37k 2,746 shares | -2% | +44% from low-47% from high | |
| 3Weak | Darwin Lewis director buy | $4,873 379 shares | +0% | +33% from low-51% from high | |
| 28Weak | Garry Paul Mauro director buy | $26k 2,150 shares | +3% | +31% from low-52% from high | |
| 38Weak | Michael A Beindorff director sell | $114k 5,850 shares | -12% | - | |
| 34Weak | Raymond B Greer director sell | $161k 8,000 shares | -7% | - | |
| 0Weak | Darwin Lewis director buy | $3,632 227 shares | +0% | - | |
| 21Weak | Michael A Beindorff director sell | $33k 5,500 shares | -9% | +106% from low-29% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 3, 2026 | BEINDORFF MICHAEL A Director | 10,000 0.08% of outstanding | $87k | Jun 3, 2026 | none |
| Nov 7, 2025 | BEINDORFF MICHAEL A Director | 54,107 0.43% of outstanding | $365k | Nov 7, 2025 | $47k |
| Feb 10, 2025 | BEINDORFF MICHAEL A Director | 6,000 0.05% of outstanding | $116k | Feb 10, 2025 | none |
| Feb 10, 2025 | Greer Raymond B Director | 8,000 0.06% of outstanding | $160k | Feb 10, 2025 | none |
| Feb 10, 2025 | Latham Cynthia Director | 5,000 0.04% of outstanding | $100k | Feb 10, 2025 | none |
Transactions
The newest 50 of 152 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Carl Aure Chief Financial Officer | AGrant or award Common Stock | +35,749 | $0.00 | $0 | 191,784 | 4 d ago |
| Oct 7, 2026 | Kristen Cunningham Chief Sales Officer | AGrant or award Common Stock | +32,850 | $0.00 | $0 | 152,375 | 4 d ago |
| Oct 7, 2026 | Terrence Moorehead President and CEO | AGrant or award Common Stock | +193,237 | $0.00 | $0 | 501,879 | 4 d ago |
| Oct 7, 2026 | Terrence Moorehead President and CEO | AGrant or award Performance Restricted Stock Unitsderivative | +289,855 | $0.00 | $0 | 289,855 | 4 d ago |
| Oct 7, 2026 | Carl Aure Chief Financial Officer | AGrant or award Performance Restricted Stock Unitsderivative | +53,623 | $0.00 | $0 | 53,623 | 4 d ago |
| Oct 7, 2026 | Kristen Cunningham Chief Sales Officer | AGrant or award Performance Restricted Stock Unitsderivative | +49,275 | $0.00 | $0 | 49,275 | 4 d ago |
| Oct 1, 2026 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -460 | $6.24 | $2,870 | 156,035 | 8 d ago |
| Oct 1, 2026 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -637 | $6.24 | $3,975 | 119,525 | 8 d ago |
| Sep 15, 2026 | Darwin Lewis director | POpen-market purchase Common Stock10b5-1 | +976 | $6.22 | $6,071 | 138,244 | 26 d ago |
| Sep 10, 2026 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -1,869 | $6.37 | $12k | 156,495 | 29 d ago |
| Sep 10, 2026 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -2,254 | $6.37 | $14k | 129,163 | 29 d ago |
| Sep 11, 2026 | Kristen Cunningham Chief Sales Officer | SOpen-market sale Common Stock | -100 | $6.41 | $641 | 129,063 | 29 d ago |
| Sep 14, 2026 | Kristen Cunningham Chief Sales Officer | SOpen-market sale Common Stock | -8,901 | $6.18 | $55k | 120,162 | 29 d ago |
| Aug 6, 2026 | Terrence Moorehead President and CEO | AGrant or award Common Stock | +308,642 | $0.00 | $0 | 308,642 | Aug 10, 2026 |
| Aug 6, 2026 | Terrence Moorehead President and CEO | AGrant or award Performance Restricted Stock Unitsderivative | +540,123 | $0.00 | $0 | 540,123 | Aug 10, 2026 |
| Jul 1, 2026 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -1,361 | $6.25 | $8,506 | 155,554 | Jul 6, 2026 |
| Jul 1, 2026 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -1,717 | $6.25 | $11k | 131,417 | Jul 6, 2026 |
| Jul 1, 2026 | Alissa Neufeld General Counsel | FTax withholding Common Stock | -1,342 | $6.25 | $8,388 | 112,744 | Jul 6, 2026 |
| Jun 15, 2026 | Darwin Lewis director | POpen-market purchase Common Stock10b5-1 | +705 | $8.60 | $6,059 | 137,268 | Jun 17, 2026 |
| Jun 3, 2026 | Michael A Beindorff director | SOpen-market sale Common Stockindirect: By Trust | -10,000 | $8.55 | $85k | 41,625 | Jun 5, 2026 |
| Apr 1, 2026 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -1,527 | $4.20 | $6,413 | 156,915 | Apr 3, 2026 |
| Apr 1, 2026 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -1,928 | $4.20 | $8,098 | 133,134 | Apr 3, 2026 |
| Apr 1, 2026 | Steven R Fife President and CEO | FTax withholding Common Stock | -8,180 | $4.20 | $34k | 735,471 | Apr 3, 2026 |
| Apr 1, 2026 | Alissa Neufeld General Counsel | FTax withholding Common Stock | -1,446 | $4.20 | $6,073 | 114,086 | Apr 3, 2026 |
| Mar 16, 2026 | Darwin Lewis director | POpen-market purchase Common Stock10b5-1 | +1,055 | $5.23 | $5,518 | 136,563 | Mar 18, 2026 |
| Feb 26, 2026 | Judd Dayton director | POpen-market purchase Common Stock | +4,600 | $4.58 | $21k | 51,762 | Mar 2, 2026 |
| Feb 27, 2026 | Judd Dayton director | POpen-market purchase Common Stock | +18,097 | $4.63 | $84k | 69,859 | Mar 2, 2026 |
| Mar 2, 2026 | Judd Dayton director | POpen-market purchase Common Stock | +10,500 | $4.53 | $48k | 80,359 | Mar 2, 2026 |
| Feb 9, 2026 | Darwin Lewis director | POpen-market purchase Common Stock | +3,955 | $5.22 | $21k | 135,508 | Feb 11, 2026 |
| Jan 1, 2026 | Steven R Fife President and CEO | FTax withholding Common Stock | -9,169 | $6.16 | $56k | 743,651 | Jan 5, 2026 |
| Jan 1, 2026 | Alissa Neufeld General Counsel | FTax withholding Common Stock | -1,445 | $6.16 | $8,901 | 115,532 | Jan 5, 2026 |
| Jan 1, 2026 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -1,527 | $6.16 | $9,406 | 158,442 | Jan 5, 2026 |
| Jan 1, 2026 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -1,926 | $6.16 | $12k | 135,060 | Jan 5, 2026 |
| Dec 23, 2025 | Todd Thompson Chief Information Officer | FTax withholding Common Stock | -601 | $6.23 | $3,744 | 50,729 | Dec 29, 2025 |
| Dec 15, 2025 | Darwin Lewis director | POpen-market purchase Common Stock10b5-1 | +805 | $6.54 | $5,265 | 131,553 | Dec 17, 2025 |
| Nov 25, 2025 | Michael A Beindorff director | GGift Common Stock | -7,819 | $0.00 | $0 | 27,570 | Dec 17, 2025 |
| Nov 25, 2025 | Michael A Beindorff director | GGift Common Stockindirect: By Trust | +7,819 | $0.00 | $0 | 51,625 | Dec 17, 2025 |
| Nov 19, 2025 | Michael A Beindorff director | SOpen-market sale Common Stockindirect: By Trust | -12,607 | $6.42 | $81k | 43,806 | Nov 21, 2025 |
| Nov 6, 2025 | Rajendran Anbalagan director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 23,999 | Nov 10, 2025 |
| Nov 6, 2025 | Michael A Beindorff director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 36,389 | Nov 10, 2025 |
| Nov 6, 2025 | Judd Dayton director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 47,162 | Nov 10, 2025 |
| Nov 6, 2025 | Raymond B Greer director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 112,819 | Nov 10, 2025 |
| Nov 6, 2025 | Cynthia Latham director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 64,879 | Nov 10, 2025 |
| Nov 6, 2025 | Darwin Lewis director | AGrant or award Common Stock | +13,531 | $7.76 | $105k | 130,748 | Nov 10, 2025 |
| Nov 7, 2025 | Michael A Beindorff director | SOpen-market sale Common Stock | -1,000 | $7.33 | $7,330 | 35,389 | Nov 10, 2025 |
| Nov 7, 2025 | Michael A Beindorff director | SOpen-market sale Common Stockindirect: By Trust | -35,000 | $6.92 | $242k | 56,413 | Nov 10, 2025 |
| Oct 1, 2025 | Carl Aure Chief Financial Officer | FTax withholding Common Stock | -1,361 | $9.56 | $13k | 159,969 | Oct 3, 2025 |
| Oct 1, 2025 | Julie Boyster Chief Marketing Officer | FTax withholding Common Stock | -1,835 | $9.56 | $18k | 150,088 | Oct 3, 2025 |
| Oct 1, 2025 | Kristen Cunningham Chief Sales Officer | FTax withholding Common Stock | -1,720 | $9.56 | $16k | 136,986 | Oct 3, 2025 |
| Oct 1, 2025 | Steven R Fife President and CEO | FTax withholding Common Stock | -8,181 | $9.56 | $78k | 752,820 | Oct 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Rajendran Anbalagandirector
- Carl AureChief Financial Officer
- Michael A Beindorffdirector
- Julie BoysterChief Marketing Officer
- Kristen CunninghamChief Sales Officer
- Judd Daytondirector, owner, ceo, officer
- Steven R FifePresident and CEO
- Raymond B Greerdirector
- Cynthia Lathamdirector
- Darwin Lewisdirector
- Garry Paul Maurodirector
- Terrence MooreheadPresident and CEO
- Alissa NeufeldGeneral Counsel
- Todd ThompsonChief Information Officer
Questions about LFVN
Answered from the filings on this page, as of the latest one.
Are insiders buying LFVN?
As of Oct 9, 2026, SEC Form 4 filings show 1 open-market buy worth $6,071 by 1 insider and 1 open-market sell worth $56k by 1 insider at Lifevantage Corp in the last 90 days, net -$50k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade LFVN on the open market?
Darwin Lewis (director) bought $6,071 of LFVN on Sep 15, 2026 and filed the Form 4 on Sep 17, 2026. InsiderTell scored 0 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at Lifevantage Corp?
14 people have filed a Form 4 at Lifevantage Corp, among them Rajendran Anbalagan (director), Carl Aure (Chief Financial Officer), Michael A Beindorff (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.